La Jolla Institute Scientists Reveal Potential New Drug Target for the Treatment of Rheumatoid Arthritis
La Jolla Institute for ImmunologyResearchers at the La Jolla Institute for Allergy and Immunology, in collaboration with colleagues the University of California, San Diego, identified a novel drug target for the treatment of rheumatoid arthritis that focuses on the cells that are directly responsible for the cartilage damage in affected joints.